The invention relates to the use of a combination of at least two markers that are selected from among Uromodulin, MAC2BP, AGP1 and Cathepsin A, for the in vitro detection of fibrotic alterations. In addition, the invention relates to a kit for determining the levels of said markers in a biological sample.

 
Web www.patentalert.com

< SYSTEM AND METHOD FOR USE OF NANOPARTICLES IN IMAGING AND TEMPERATURE MEASUREMENT

> Dynamic nuclear polarization enhanced nuclear magnetic resonance of water under ambient conditions

> Antenna For Picking up Magnetic Resonance Signals and Provided With Its Own Communication Unit
~ 00518